FDA Clearance Tracker · K253573
ASTar BC G- Kit
Last checked: Nov 19, 2026Latest source record: Apr 15, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 15, 2026
Substantially Equivalent
Time to decision
149 days
Received Nov 17, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K253573
- Device name
- ASTar BC G- Kit
- Applicant
- Q-Linea AB
- Applicant location
- Uppsala, SE
- Received
- Nov 17, 2025
- Decided
- Apr 15, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples (SAN)
- Device class
- Class II
- Regulation
- 21 CFR 866.1650
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code SAN. The earliest in FDA's data is K211815, decided Apr 2, 2024.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K253573
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Q-Linea AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ASTar BC G- Kit and ASTar InstrumentBreakthrough510(k)
K221688 · Decided Apr 26, 2024 · 686 days after receipt
Device type: Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples (SAN) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.